Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy

References

• Felgner S, Kocijancic D, Frahm M, Weiss S. Bacteria in Cancer Therapy: Renaissance of an Old Concept. Int J Microbiol. 2016;2016:1-14. doi:10.1155/2016/8451728.
   Google Scholar
• Forbes NS. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer. 2010;10:785-94. doi:10.1038/nrc2934.
   PubMed Web of Science ®Google Scholar
• Frahm M, Felgner S, Kocijancic D, Rohde M, Hensel M, Curtiss R, Erhardt M, Weiss S. Efficiency of Conditionally Attenuated Salmonella enterica Serovar Typhimurium in Bacterium-Mediated Tumor Therapy. mBio. 2015;6:e00254-15. doi:10.1128/mBio.00254-15.
   PubMed Web of Science ®Google Scholar
• Eisenstark A, Kazmierczak RA, Dino A, Khreis R, Newman D, Schatten H. Development of Salmonella strains as cancer therapy agents and testing in tumor cell lines. Methods Mol Biol. 2007;394:323-54.
   PubMedGoogle Scholar
• Kocijancic D, Felgner S, Frahm M, Komoll R-M, Iljazovic A, Pawar V, Rohde M, Heise U, Zimmermann K, Gunzer F, et al. Therapy of solid tumors using probiotic Symbioflor-2 – restraints and potential. Oncotarget;2016;7:22605-22. doi:10.18632/oncotarget.8027.
   PubMed Web of Science ®Google Scholar
• Singh R, Paterson Y. Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy. Expert Rev Vaccines. 2006;5:541-52. doi:10.1586/14760584.5.4.541.
   PubMed Web of Science ®Google Scholar
• Zhao M, Yang M, Ma H, Li X, Tan X, Li S, Yang Z, Hoffman RM. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res. 2006;66:7647-52. doi:10.1158/0008-5472.CAN-06-0716.
   PubMed Web of Science ®Google Scholar
• Hoffman RM. The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages. Expert Opin Drug Discov. 2012;7:73-83. doi:10.1517/17460441.2012.644534.
   PubMed Web of Science ®Google Scholar
• Swofford CA, Van Dessel N, Forbes NS. Quorum-sensing Salmonella selectively trigger protein expression within tumors. PNAS. 2015;112:3457-62. doi:10.1073/pnas.1414558112.
   PubMed Web of Science ®Google Scholar
• Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. PNAS. 2007;104:10170-4. doi:10.1073/pnas.0703867104.
   PubMed Web of Science ®Google Scholar
• Low KB, Ittensohn M, Luo X, Zheng L-M, King I, Pawelek JM, Bermudes D. Construction of VNP20009. In: Springer C.J. (eds) Suicide Gene Therapy. Methods in Molecular Medicine™, 2004;vol 90. Humana Press. doi:10.1385/1-59259-429-8:47
   Google Scholar
• Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, et al. Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma. J Clin Oncol. 2002;20:142-52. doi:10.1200/JCO.2002.20.1.142.
   PubMed Web of Science ®Google Scholar
• Krick EL, Sorenmo KU, Rankin SC, Cheong I, Kobrin B, Thornton K, Kinzler KW, Vogelstein B, Zhou S, Diaz LA. Evaluation of Clostridium novyi-NT spores in dogs with naturally occurring tumors. Am J Vet Res. 2012;73:112-8. doi:10.2460/ajvr.73.1.112. PMID:22849671
   PubMed Web of Science ®Google Scholar
• Roberts NJ, Zhang L, Janku F, Collins A, Bai R-Y, Staedtke V, Rusk AW, Tung D, Miller M, Roix J, et al. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Sci Transl Med. 2014;6:249ra111-249ra111. doi:10.1126/scitranslmed.3008982.
   PubMed Web of Science ®Google Scholar
• Swofford CA, St Jean AT, Panteli JT, Brentzel ZJ, Forbes NS. Identification of Staphylococcus aureus α-hemolysin as a protein drug that is secreted by anticancer bacteria and rapidly kills cancer cells. Biotechnol Bioeng. 2014;111:1-32. doi:10.1002/bit.25184.
   PubMed Web of Science ®Google Scholar
• Green L, Storey M, Williams E, Patterson A, Smaill J, Copp J, Ackerley D. The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy. Cancers. 2013;5:985-97. doi:10.3390/cancers5030985.
   PubMedGoogle Scholar
• Leschner S, Westphal K, Dietrich N, Viegas N, Jablonska J, Lyszkiewicz M, Lienenklaus S, Falk W, Gekara N, Loessner H, et al. Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α. PLoS One. 2009;4:e6692. doi:10.1371/journal.pone.0006692. PMID:19693266
   PubMed Web of Science ®Google Scholar
• Stern C, Kasnitz N, Kocijancic D, Trittel S, Riese P, Guzman CA, Leschner S, Weiss S. Induction of CD4+ and CD8+ anti-tumor effector T cell responses by bacteria mediated tumor therapy. Int J Cancer. 2015;137:2019-28. doi:10.1002/ijc.29567.
   PubMed Web of Science ®Google Scholar
• Zhao M, Yang M, Li X-M, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. PNAS. 2005;102:755-60. doi:10.1073/pnas.0408422102.
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Zhang Y, Zhao M, Zhang N, Murakami T, Maawy A, Mii S, Uehara F, Yamamoto M, Miwa S, et al. Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models. PLoS One. 2015;10:e0120358. doi:10.1371/journal.pone.0120358. PMID:26047477
   PubMed Web of Science ®Google Scholar
• Uchugonova A, Zhang Y, Salz R, Liu F, Suetsugu A, Zhang L, Koenig K, Hoffman RM, Zhao M. Imaging the different mechanisms of prostate cancer cell-killing by tumor-targeting Salmonella typhimurium A1-R. Anticancer Res. 2015;35:5225-30.
   PubMed Web of Science ®Google Scholar
• Mercado-Lubo R, Zhang Y, Zhao L, Rossi K, Wu X, Zou Y, Castillo A, Leonard J, Bortell R, Greiner DL, et al. A Salmonella nanoparticle mimic overcomes multidrug resistance in tumours. Nat Commun. 2016;7:12225. doi:10.1038/ncomms12225.
   PubMed Web of Science ®Google Scholar
• Mandell D, Bennett JE. Principles and Practice of Infectious Diseases. 7th Edition. Cambridge, UK: Elsevier. 2010.
   Google Scholar
• Enck P, Zimmermann K, Menke G, Klosterhalfen S. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo. Z Gastroenterol. 2009;47:209-14. doi:10.1055/s-2008-1027702.
   PubMed Web of Science ®Google Scholar
• Zschüttig A, Auerbach C, Meltke S, Eichhorn C, Brandt M, Blom J, Goesmann A, Jarek M, Scharfe M, Zimmermann K, et al. Complete Sequence of Probiotic Symbioflor 2 Escherichia coli Strain G3/10 and Draft Sequences of Symbioflor 2 E. coli Strains G1/2, G4/9, G5, G6/7, and G8. Genome Announc. 2015;3. doi:10.1128/genomeA.01330-14.
   PubMedGoogle Scholar
• Needham BD, Carroll SM, Giles DK, Georgiou G, Whiteley M, Trent MS. Modulating the innate immune response by combinatorial engineering of endotoxin. PNAS. 2013;110:1469-9. doi:10.1073/pnas.1218080110.
   Web of Science ®Google Scholar
• Park BS, Song DH, Kim HM, Choi B-S, Lee H, Lee J-O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 2009;458:1191-5. doi:10.1038/nature07830.
   PubMed Web of Science ®Google Scholar
• Felgner S, Frahm M, Kocijancic D, Rohde M, Eckweiler D, Bielecka A, Bueno E, Cava F, Abraham W-R, Curtiss R, et al. aroA-Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant. mBio. 2016;7:e01220-16. doi:10.1128/mBio.01220-16.
   PubMed Web of Science ®Google Scholar
• Takaya A, Erhardt M, Karata K, Winterberg K, Yamamoto T, Hughes KT. YdiV: a dual function protein that targets FlhDC for ClpXP-dependent degradation by promoting release of DNA-bound FlhDC complex. Mol Microbiol. 2012;83:1268-84. doi:10.1111/j.1365-2958.2012.08007.x.
   PubMed Web of Science ®Google Scholar
• Erhardt M, Namba K, Hughes KT. Bacterial nanomachines: the flagellum and type III injectisome. Cold Spring Harb. Perspect. Biol. 2010;2. doi:10.1101/cshperspect.a000299. PMID:20926516
   PubMed Web of Science ®Google Scholar
• Kocijancic D, Felgner S, Schauer T, Frahm M, Heise U, Zimmermann K, Erhardt M, Weiss S. Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection. Oncotarget. 2017;8:49988-50001. PMID:28637010
   PubMed Web of Science ®Google Scholar
• Westphal K, Leschner S, Jablonska J, Loessner H, Weiss S. Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res. 2008;68:2952-60. doi:10.1158/0008-5472.CAN-07-2984.
   PubMed Web of Science ®Google Scholar
• Kocijancic D, Leschner S, Felgner S, Komoll R-M, Frahm M, Pawar V, Weiss S. Therapeutic benefit of Salmonella attributed to LPS and TNF-alpha is exhaustible and dictated by tumor susceptibility. Oncotarget. 2017;8:36492-508.
   PubMed Web of Science ®Google Scholar
• Crull K, Bumann D, Weiss S. Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium. FEMS Immunol Med Microbiol. 2011;62:75-83. doi:10.1111/j.1574-695X.2011.00790.x.
   PubMed Web of Science ®Google Scholar
• Felgner S, Kocijancic D, Pawar V, Weiss S. Biomimetic Salmonella: A Next-Generation Therapeutic Vector? Trends Microbiol. 2016;24:850-2. doi:10.1016/j.tim.2016.08.007.
   PubMed Web of Science ®Google Scholar
• Clairmont C, Lee KC, Pike J, Ittensohn M, Low KB, Pawelek J, Bermudes D, Brecher SM, Margitich D, Turnier J, et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis. 2000;181:1996-2002. doi:10.1086/315497.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang N, Zhao M, Hoffman RM. Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice. Oncotarget. 2015;6:14625-31.
   PubMed Web of Science ®Google Scholar
• WHO. Typhoid vaccines: WHO position papers. Wkly Epidemiol Rec. 2008;83:49-60.
   PubMedGoogle Scholar
• Felgner S, Kocijancic D, Frahm M, Curtiss R, Erhardt M, Weiss S. Optimizing Salmonella enterica Serovar Typhimurium for Bacteria-mediated Tumor Therapy. Gut Microbes. 2016;7:171-7. doi:10.1080/19490976.2016.1155021.
   PubMed Web of Science ®Google Scholar
• Zheng JH, Nguyen VH, Jiang S-N, Park S-H, Tan W, Hong SH, Shin MG, Chung I-J, Hong Y, Bom H-S, et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci Transl Med. 2017;9:eaak9537 doi:10.1126/scitranslmed.aak9537. PMID:28179508
   PubMed Web of Science ®Google Scholar
• Kim J-E, Phan TX, Nguyen VH, Dinh-Vu H-V, Zheng JH, Yun M, Park S-G, Hong Y, Choy HE, Szardenings M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42. doi:10.7150/thno.11432.
   PubMed Web of Science ®Google Scholar
• Phan TX, Nguyen VH, Duong MTQ, Hong Y, Choy HE, Min JJ. Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy. Microbiol Immunol. 2015;59:664-75. doi:10.1111/1348-0421.12333.
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Zhao M, Maawy A, Zhang Y, Katz MHG, Fleming JB, Uehara F, Miwa S, Yano S, Momiyama M, et al. Efficacy of Salmonella typhimurium A1-R Versus Chemotherapy on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX). J Cell Biochem. 2014;115:1254-61. doi:10.1002/jcb.24769.
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Zhang Y, Murakami T, Maawy A, Miwa S, Yamamoto M, Yano S, Sato S, Momiyama M, Mori R, et al. Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models. Oncotarget. 2014;5:12346-57. doi:10.18632/oncotarget.2641.
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Zhao M, Zhang Y, Zhang N, Maawy A, Murakami T, Mii S, Uehara F, Yamamoto M, Miwa S, et al. Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice. PLoS One. 2015;10:e0134324. doi:10.1371/journal.pone.0134324. PMID:26237416
   PubMed Web of Science ®Google Scholar
• Murakami T, DeLong J, Eilber FC, Zhao M, Zhang Y, Zhang N, Singh A, Russell T, Deng S, Reynoso J, et al. Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model. Oncotarget. 2016;7:12783-90. doi:10.18632/oncotarget.7226.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Zhao M, Hiroshima Y, Zhang Y, Shurell E, Eilber FC, Bouvet M, Noda M, Hoffman RM. Efficacy of tumor-targeting Salmonella A1-R on a melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. PLoS One. 2016;11:e0160882. doi:10.1371/journal.pone.0160882. PMID:27500926
   PubMed Web of Science ®Google Scholar
• Kawaguchi K, Igarashi K, Murakami T, Chmielowski B, Kiyuna T, Zhao M, Zhang Y, Singh A, Unno M, Nelson SD, et al. Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model. Oncotarget. 2016;7:85929-36.
   PubMed Web of Science ®Google Scholar
• Murakami T, Igarashi K, Kawaguchi K, Kiyuna T, Zhang Y, Zhao M, Hiroshima Y, Nelson SD, Dry SM, Li Y, et al. Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug. Oncotarget. 2017;8:8035-42.
   PubMed Web of Science ®Google Scholar
• Nguyen VH, Kim H-S, Ha J-M, Hong Y, Choy HE, Min J-J. Genetically Engineered Salmonella typhimurium as an Imageable Therapeutic Probe for Cancer. Cancer Res [Internet]. 2010;70:18 LP-23.
   Web of Science ®Google Scholar
• Eom JS, Seok Kim J, Im Jang J, Kim B-H, Young Yoo S, Hyeon Choi J, Bang I-S, Lee IS, Keun Park Y. Enhancement of host immune responses by oral vaccination to Salmonella enterica serovar Typhimurium harboring both FliC and FljB flagella. PLoS One. 2013;8:e74850. doi:10.1371/journal.pone.0074850. PMID:24069357
   PubMed Web of Science ®Google Scholar
• Olsen JE, Hoegh-Andersen KH, Casadesús J, Rosenkranzt J, Chadfield MS, Thomsen LE. The role of flagella and chemotaxis genes in host pathogen interaction of the host adapted Salmonella enterica serovar Dublin compared to the broad host range serovar S. Typhimurium. BMC Microbiol. 2013;67. doi:10.1186/1471-2180-13-67.
   PubMed Web of Science ®Google Scholar
• Andzinski L, Kasnitz N, Stahnke S, Wu CF, Gereke M, Von Köckritz-Blickwede M, Schilling B, Brandau S, Weiss S, Jablonska J. Type i IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int J Cancer. 2016;138:1982-93. doi:10.1002/ijc.29945.
   PubMed Web of Science ®Google Scholar
• Dean P. Functional domains and motifs of bacterial type III effector proteins and their roles in infection. FEMS Microbiol Rev. 2011;1100-25.
   PubMed Web of Science ®Google Scholar
• Xu X, Hegazy WAH, Guo L, Gao X, Courtney AN, Kurbanov S, Liu D, Tian G, Manuel ER, Diamond DJ, et al. Development of an Effective Cancer Vaccine Using Attenuated Salmonella and Type III Secretion System to Deliver Recombinant Tumor-Associated Antigens. Cancer Res. 2014;74:6260-70.
   PubMed Web of Science ®Google Scholar
• Jeong J-H, Kim K, Lim D, Jeong K, Hong Y, Nguyen VH, Kim T-H, Ryu S, Lim J-A, Kim J Il, et al. Anti-Tumoral Effect of the Mitochondrial Target Domain of Noxa Delivered by an Engineered Salmonella typhimurium. PLoS One. 2014;9:e80050. doi:10.1371/journal.pone.0080050. PMID:24416126
   PubMed Web of Science ®Google Scholar
• McCarthy EF. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J. 2006;26:154-8.
   PubMedGoogle Scholar
• Johnston BJ, Novales ET. Clinical effect of Coley's toxin. A seven-year study. Cancer Chemother reports. 1962;21:43.
   PubMedGoogle Scholar
• Moest TP, Méresse S. Salmonella T3SSs: successful mission of the secret(ion) agents. Curr Opin Microbiol. 2013;16:38-44. doi:10.1016/j.mib.2012.11.006.
   PubMed Web of Science ®Google Scholar